Kenneth Offit, MD
Kenneth Offit, MD
Chief, Clinical Genetics Service
Memorial Sloan-Kettering Cancer Center
1275 York Avenue
New York,
NY
USA
10065
Papers:
193 - Poster Session A
Breast cancer risk with hormone replacement after risk-reducing Salpingo-oophorectomy in BRCA mutation carriers: does it abrogate the benefit?
Late Breaking Abstract 5
Risk of developing uterine corpus cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations